- Home
- VIVS vs LDWY Comparison
VIVS vs LDWY Comparison
Compare VIVS & LDWY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIVS
- LDWY
- Stock Information
- Founded
- VIVS 2007
- LDWY 1990
- Country
- VIVS United States
- LDWY United States
- Employees
- VIVS N/A
- LDWY N/A
- Industry
- VIVS Biotechnology: Biological Products (No Diagnostic Substances)
- LDWY Advertising
- Sector
- VIVS Health Care
- LDWY Consumer Discretionary
- Exchange
- VIVS Nasdaq
- LDWY Nasdaq
- Market Cap
- VIVS 8.1M
- LDWY 8.9M
- IPO Year
- VIVS N/A
- LDWY 1991
- Fundamental
- Price
- VIVS $2.28
- LDWY $4.40
- Analyst Decision
- VIVS
- LDWY
- Analyst Count
- VIVS 0
- LDWY 0
- Target Price
- VIVS N/A
- LDWY N/A
- AVG Volume (30 Days)
- VIVS 104.1K
- LDWY 1.6K
- Earning Date
- VIVS 11-12-2025
- LDWY 11-18-2025
- Dividend Yield
- VIVS N/A
- LDWY N/A
- EPS Growth
- VIVS N/A
- LDWY N/A
- EPS
- VIVS N/A
- LDWY 1.66
- Revenue
- VIVS $142,000.00
- LDWY $71,244,000.00
- Revenue This Year
- VIVS $42.38
- LDWY N/A
- Revenue Next Year
- VIVS $15.42
- LDWY N/A
- P/E Ratio
- VIVS N/A
- LDWY $2.73
- Revenue Growth
- VIVS 94.52
- LDWY 187.12
- 52 Week Low
- VIVS $1.41
- LDWY $3.26
- 52 Week High
- VIVS $21.96
- LDWY $6.19
- Technical
- Relative Strength Index (RSI)
- VIVS 38.84
- LDWY 34.90
- Support Level
- VIVS $2.14
- LDWY $4.63
- Resistance Level
- VIVS $2.44
- LDWY $5.04
- Average True Range (ATR)
- VIVS 0.27
- LDWY 0.15
- MACD
- VIVS -0.09
- LDWY -0.06
- Stochastic Oscillator
- VIVS 10.00
- LDWY 21.12
About VIVS VivoSim Labs Inc. Common Stock
VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases. It is now offering liver toxicology predictive screening and research services as well as working on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at all stages of drug development.
About LDWY Lendway Inc. (DE)
Lendway Inc is a specialty agricultural and finance company focused on making and managing its ag investments in the United States and internationally. The company operates in two industries: Specialty Ag, consisting of the Bloomia business, and Non-bank Lending, consisting of the Lending Business.